Cardiol Therapeutics (CRDL) Other Non Operating Income (2020 - 2026)

Cardiol Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $158237.6 for Q1 2026.

• Quarterly Other Non Operating Income rose 312.48% year-over-year to $158237.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$614894.7 (down 161.07% YoY) and the FY2025 annual result came in at -$846679.6, down 155.28% from the prior year.
• Other Non Operating Income was $158237.6 for Q1 2026 at Cardiol Therapeutics, up from -$221254.1 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.3 million in Q3 2022 and bottomed at -$1.1 million in Q1 2022.
• A 5-year average of $145123.3 and a median of $56802.8 in 2023 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 2201.1% in 2022, while the deepest fall reached 2657.74% in 2022.
• Cardiol Therapeutics' Other Non Operating Income stood at -$389210.5 in 2022, then dropped by 18.55% to -$461397.0 in 2023, then surged by 332.83% to $1.1 million in 2024, then tumbled by 120.6% to -$221254.1 in 2025, then jumped by 171.52% to $158237.6 in 2026.
• Business Quant data shows CRDL's Other Non Operating Income at $158237.6 in Q1 2026, -$221254.1 in Q4 2025, and $67986.2 in Q3 2025.